CA2291260A1 - 207 human secreted proteins - Google Patents

207 human secreted proteins Download PDF

Info

Publication number
CA2291260A1
CA2291260A1 CA002291260A CA2291260A CA2291260A1 CA 2291260 A1 CA2291260 A1 CA 2291260A1 CA 002291260 A CA002291260 A CA 002291260A CA 2291260 A CA2291260 A CA 2291260A CA 2291260 A1 CA2291260 A1 CA 2291260A1
Authority
CA
Canada
Prior art keywords
gene
tissues
polypeptides
seq
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002291260A
Other languages
English (en)
French (fr)
Inventor
Paul Young
John M. Greene
Ann M. Ferrie
Steven M. Ruben
Craig A. Rosen
Jing-Shan Hu
Henrik S. Olsen
Reinhard Ebner
Laurie A. Brewer
Paul A. Moore
Yanggu Shi
Charles Florence
Kimberly Florence
David W. Lafleur
Jian Ni
Ping Fan
Ying-Fei Wei
Carrie L. Fischer
Daniel R. Soppet
Yi Li
Zhizhen Zeng
Hla Kyaw
Guo-Liang Yu
Ping Feng
Patrick J. Dillon
Gregory A. Endress
Kenneth C. Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2291260A1 publication Critical patent/CA2291260A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002291260A 1997-06-06 1998-06-04 207 human secreted proteins Abandoned CA2291260A1 (en)

Applications Claiming Priority (147)

Application Number Priority Date Filing Date Title
US4889897P 1997-06-06 1997-06-06
US4888197P 1997-06-06 1997-06-06
US4887597P 1997-06-06 1997-06-06
US4891597P 1997-06-06 1997-06-06
US4889397P 1997-06-06 1997-06-06
US4937397P 1997-06-06 1997-06-06
US4896297P 1997-06-06 1997-06-06
US4888497P 1997-06-06 1997-06-06
US4888397P 1997-06-06 1997-06-06
US4887697P 1997-06-06 1997-06-06
US4897197P 1997-06-06 1997-06-06
US4890097P 1997-06-06 1997-06-06
US4902097P 1997-06-06 1997-06-06
US4937597P 1997-06-06 1997-06-06
US4896497P 1997-06-06 1997-06-06
US4891797P 1997-06-06 1997-06-06
US4887897P 1997-06-06 1997-06-06
US4896397P 1997-06-06 1997-06-06
US4889797P 1997-06-06 1997-06-06
US4889697P 1997-06-06 1997-06-06
US4890197P 1997-06-06 1997-06-06
US4894997P 1997-06-06 1997-06-06
US4889597P 1997-06-06 1997-06-06
US4889297P 1997-06-06 1997-06-06
US4897297P 1997-06-06 1997-06-06
US4897497P 1997-06-06 1997-06-06
US4891697P 1997-06-06 1997-06-06
US4888097P 1997-06-06 1997-06-06
US4901997P 1997-06-06 1997-06-06
US4937497P 1997-06-06 1997-06-06
US4888597P 1997-06-06 1997-06-06
US4888297P 1997-06-06 1997-06-06
US4889997P 1997-06-06 1997-06-06
US4887797P 1997-06-06 1997-06-06
US4897097P 1997-06-06 1997-06-06
US4889497P 1997-06-06 1997-06-06
US60/048,901 1997-06-06
US60/048,880 1997-06-06
US60/049,374 1997-06-06
US60/048,885 1997-06-06
US60/048,881 1997-06-06
US60/048,971 1997-06-06
US60/048,915 1997-06-06
US60/048,895 1997-06-06
US60/048,916 1997-06-06
US60/048,896 1997-06-06
US60/049,019 1997-06-06
US60/049,020 1997-06-06
US60/048,894 1997-06-06
US60/048,892 1997-06-06
US60/048,974 1997-06-06
US60/049,373 1997-06-06
US60/048,964 1997-06-06
US60/048,917 1997-06-06
US60/048,899 1997-06-06
US60/048,878 1997-06-06
US60/048,900 1997-06-06
US60/048,876 1997-06-06
US60/048,893 1997-06-06
US60/048,883 1997-06-06
US60/048,877 1997-06-06
US60/048,972 1997-06-06
US60/048,875 1997-06-06
US60/048,884 1997-06-06
US60/048,962 1997-06-06
US60/048,898 1997-06-06
US60/048,949 1997-06-06
US60/048,882 1997-06-06
US60/048,963 1997-06-06
US60/048,897 1997-06-06
US60/049,375 1997-06-06
US5777897P 1997-09-05 1997-09-05
US5763597P 1997-09-05 1997-09-05
US5766197P 1997-09-05 1997-09-05
US5765197P 1997-09-05 1997-09-05
US5766897P 1997-09-05 1997-09-05
US5764997P 1997-09-05 1997-09-05
US5777497P 1997-09-05 1997-09-05
US5777597P 1997-09-05 1997-09-05
US5776597P 1997-09-05 1997-09-05
US5777197P 1997-09-05 1997-09-05
US5764497P 1997-09-05 1997-09-05
US5758497P 1997-09-05 1997-09-05
US5776197P 1997-09-05 1997-09-05
US5776097P 1997-09-05 1997-09-05
US5762897P 1997-09-05 1997-09-05
US5777797P 1997-09-05 1997-09-05
US5762997P 1997-09-05 1997-09-05
US5765097P 1997-09-05 1997-09-05
US5766797P 1997-09-05 1997-09-05
US5764797P 1997-09-05 1997-09-05
US5776997P 1997-09-05 1997-09-05
US5766297P 1997-09-05 1997-09-05
US5766697P 1997-09-05 1997-09-05
US5764397P 1997-09-05 1997-09-05
US5777697P 1997-09-05 1997-09-05
US5764897P 1997-09-05 1997-09-05
US5764697P 1997-09-05 1997-09-05
US5764597P 1997-09-05 1997-09-05
US5764297P 1997-09-05 1997-09-05
US5776497P 1997-09-05 1997-09-05
US5777097P 1997-09-05 1997-09-05
US5765497P 1997-09-05 1997-09-05
US5763497P 1997-09-05 1997-09-05
US5762797P 1997-09-05 1997-09-05
US5776297P 1997-09-05 1997-09-05
US5776397P 1997-09-05 1997-09-05
US60/057,628 1997-09-05
US60/057,654 1997-09-05
US60/057,634 1997-09-05
US60/057,774 1997-09-05
US60/057,775 1997-09-05
US60/057,770 1997-09-05
US60/057,647 1997-09-05
US60/057,760 1997-09-05
US60/057,764 1997-09-05
US60/057,776 1997-09-05
US60/057,761 1997-09-05
US60/057,645 1997-09-05
US60/057,668 1997-09-05
US60/057,643 1997-09-05
US60/057,651 1997-09-05
US60/057,649 1997-09-05
US60/057,642 1997-09-05
US60/057,769 1997-09-05
US60/057,648 1997-09-05
US60/057,644 1997-09-05
US60/057,777 1997-09-05
US60/057,661 1997-09-05
US60/057,666 1997-09-05
US60/057,646 1997-09-05
US60/057,662 1997-09-05
US60/057,778 1997-09-05
US60/057,763 1997-09-05
US60/057,584 1997-09-05
US60/057,650 1997-09-05
US60/057,629 1997-09-05
US60/057,627 1997-09-05
US60/057,635 1997-09-05
US60/057,667 1997-09-05
US60/057,771 1997-09-05
US60/057,762 1997-09-05
US7092397P 1997-12-18 1997-12-18
US60/070,923 1997-12-18
US60/048,970 1997-12-19
US60/057,765 1997-12-19
PCT/US1998/011422 WO1998054963A2 (en) 1997-06-06 1998-06-04 207 human secreted proteins

Publications (1)

Publication Number Publication Date
CA2291260A1 true CA2291260A1 (en) 1998-12-10

Family

ID=27587074

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002291260A Abandoned CA2291260A1 (en) 1997-06-06 1998-06-04 207 human secreted proteins

Country Status (3)

Country Link
EP (1) EP1039801A4 (de)
CA (1) CA2291260A1 (de)
WO (1) WO1998054963A2 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000075375A1 (en) * 1999-06-07 2000-12-14 Human Genome Sciences, Inc. 26 human secreted proteins
WO2001062891A2 (en) * 2000-02-24 2001-08-30 Human Genome Sciences, Inc. 207 human secreted proteins
EP0970209A1 (de) * 1997-03-28 2000-01-12 Genetics Institute, Inc. Sekretierte proteine und polynukleotide die für diese kodieren
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
CA2298451A1 (en) * 1997-08-06 1999-02-18 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US7378507B2 (en) * 1997-09-18 2008-05-27 Genentech, Inc. PRO217 polypeptides
US6075136A (en) * 1998-02-17 2000-06-13 Incyte Pharmaceuticals, Inc. Prostate-associated serine protease
EP0939124A3 (de) * 1998-02-24 2001-03-21 Smithkline Beecham Plc MBGP1-Sequenzen
AU2783899A (en) * 1998-02-26 1999-09-15 Human Genome Sciences, Inc. 36 human secreted proteins
EP1056847A2 (de) * 1998-02-27 2000-12-06 Sagami Chemical Research Center Menschliche proteine mit transmembranären domäne und deren kodierende nukleinsäuren
WO1999047676A1 (en) * 1998-03-18 1999-09-23 Icos Corporation Human leupaxin polypeptide and dna encoding it, their uses
GB9807722D0 (en) * 1998-04-08 1998-06-10 Smithkline Beecham Plc Novel compounds
DE19818619A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Tumor
EP1108042B1 (de) 1998-08-07 2008-11-26 Immunex Corporation B7l-1 moleküle
EP1111058A4 (de) * 1998-08-31 2003-01-02 Long Yu Neues humanes lysozymgen, das dadurch kodierte polypeptide und methode zu derenherstellung
AU2003204365B2 (en) * 1998-09-01 2006-09-07 Genentech, Inc. Further pro polypeptides and sequences thereof
JP2005502301A (ja) * 1998-09-18 2005-01-27 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒトｉｓｒｅ結合タンパク質
WO2000018923A2 (en) * 1998-09-30 2000-04-06 Millennium Pharmaceuticals, Inc. Slgp protein and nucleic acid molecule and uses therefor
US7414112B2 (en) 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
US6020164A (en) * 1998-10-21 2000-02-01 Incyte Pharmaceuticals, Inc. Human RNA binding proteins
EP1132473A4 (de) 1998-11-20 2002-06-12 Fuso Pharmaceutical Ind Serinprotease bssp6
EP1144632A3 (de) * 1998-12-23 2001-11-07 Corixa Corporation Verbindungen zur immunotherapie und diagnose von dickdarmkrebs und verfahren zu ihrer anwendung
GB9828704D0 (en) 1998-12-24 1999-02-17 Nippon Glaxo Limited Proteins
US6844325B2 (en) 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6586572B2 (en) 1998-12-28 2003-07-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6573368B2 (en) 1998-12-28 2003-06-03 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6518237B1 (en) 1998-12-28 2003-02-11 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6387697B1 (en) 1998-12-28 2002-05-14 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6590076B1 (en) 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
AU2757500A (en) * 1999-02-10 2000-08-29 Human Genome Sciences, Inc. 33 human secreted proteins
WO2000077023A1 (en) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 48 human secreted proteins
WO2000061596A1 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 50 human secreted proteins
AU3396600A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. 49 human secreted proteins
WO2000077256A1 (en) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 48 human secreted proteins
WO2000058356A1 (en) * 1999-03-26 2000-10-05 Human Genome Sciences, Inc. 50 human secreted proteins
AU4010400A (en) * 1999-03-18 2000-10-04 Human Genome Sciences, Inc. 27 human secreted proteins
JP2002539776A (ja) * 1999-03-23 2002-11-26 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４９個のヒト分泌タンパク質
AU4338100A (en) * 1999-04-09 2000-11-14 Chiron Corporation Secreted human proteins
CA2370039A1 (en) * 1999-04-09 2000-10-19 Shionogi & Co., Ltd. Apoptosis-associated gene
EP1169447A1 (de) * 1999-04-15 2002-01-09 Osiris Therapeutics, Inc. Gene und expressionsprodukte aus haemapoetischen zellen
CN1365389A (zh) * 1999-04-30 2002-08-21 宫田敏男 Meg－3蛋白
KR100798375B1 (ko) * 1999-05-13 2008-01-28 존슨 앤드 존슨 파머슈티컬 리서치 앤드 디벨로프먼트 엘엘씨 스핀고신 키나제 효소
WO2000071581A1 (fr) * 1999-05-20 2000-11-30 Takeda Chemical Industries, Ltd. Nouveau polypeptide
CA2382748A1 (en) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 50 human secreted proteins
EP1192176A4 (de) * 1999-06-11 2003-03-05 Human Genome Sciences Inc 49 menschliche sekretierte proteine
EP1196569A2 (de) * 1999-07-14 2002-04-17 Incyte Genomics, Inc. Elektrontransferproteine
WO2001009318A1 (fr) * 1999-07-29 2001-02-08 Helix Research Institute Genes associes au cancer du foie
WO2001021794A2 (en) * 1999-09-20 2001-03-29 Ludwig Institute For Cancer Research Smad associating polypeptides
US6673570B1 (en) * 1999-09-20 2004-01-06 Ludwig Institute For Cancer Research Smad associating polypeptides
WO2001021815A1 (en) * 1999-09-23 2001-03-29 Rigel Pharmaceuticals, Inc. Checkpoint gene associated cell cycle proteins, compositions and methods of use
JP2003512072A (ja) * 1999-10-28 2003-04-02 ワーナー−ランバート・カンパニー ヒトスフィンゴシンキナーゼ遺伝子
EP1248800A2 (de) 1999-11-30 2002-10-16 Corixa Corporation Kompositionen und methoden zur therapie und diagnose von brustkrebs
CA2397207C (en) 2000-01-13 2013-12-03 Genentech, Inc. Novel stra6 polypeptides
AU3828301A (en) * 2000-02-14 2001-08-27 Curagen Corp Novel sphingosine kinases
US20020098163A1 (en) * 2000-07-24 2002-07-25 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR21 and TR22
EP1339841A2 (de) * 2000-09-27 2003-09-03 Vlaams Interuniversitair Instituut voor Biotechnologie Identifizierung von tumorsuppressorgenen aus neuroblastoma
US6630325B1 (en) * 2000-10-19 2003-10-07 Maine Medical Center Research Institute Compositions, methods and kits relating to remodel
WO2003000729A2 (en) * 2001-06-20 2003-01-03 Genentech, Inc. Secreted polypeptide and their use in the treatment of bone disorders
WO2003025135A2 (en) * 2001-09-14 2003-03-27 Gene Logic, Inc. Genes associated with malignant neoplasms
EP2305710A3 (de) 2002-06-03 2013-05-29 Genentech, Inc. Synthetische Antikörperphagenbibliotheken

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871702B1 (de) * 1994-12-06 2005-05-25 Immunex Corporation Cytokin lerk-7
DE69634726T2 (de) * 1995-07-19 2006-05-04 Genetics Institute, LLC, Cambridge Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen

Also Published As

Publication number Publication date
EP1039801A4 (de) 2003-03-26
EP1039801A1 (de) 2000-10-04
WO1998054963A2 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
CA2291260A1 (en) 207 human secreted proteins
US20030055236A1 (en) Secreted protein HKABT24
US20050089911A1 (en) 87 human secreted proteins
WO2000006698A1 (en) 98 human secreted proteins
CA2295474A1 (en) 123 human secreted proteins
CA2331154A1 (en) Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
US6525174B1 (en) Precerebellin-like protein
CA2332109A1 (en) 97 human secreted proteins
CA2323761A1 (en) 95 human secreted proteins
CA2319129A1 (en) 67 human secreted proteins
WO1998054206A1 (en) 32 human secreted proteins
US6878687B1 (en) Protein HMAAD57
WO1999024836A1 (en) 125 human secreted proteins
CA2296815A1 (en) 64 human secreted proteins
CA2322728A1 (en) 31 human secreted proteins
CA2294705A1 (en) 19 human secreted proteins
CA2305690A1 (en) 53 human secreted proteins
WO1999022243A1 (en) 148 human secreted proteins
CA2298852A1 (en) 83 human secreted proteins
CA2302387A1 (en) 29 human secreted proteins
EP1019506A1 (de) 101 sekretierte proteine vom menschen.
US20050214844A1 (en) 86 human secreted proteins
US20070238664A1 (en) 70 Human Secreted Proteins
CA2383048A1 (en) 49 human secreted proteins
EP1439189A2 (de) 86 sekretierte menschliche Proteine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead